Improtaz 4000 mg/500 mg Injection
Marketer
Nippon Seiyaku Pvt Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Improtaz 4000 mg/500 mg Injection
Combiflox 4000 mg/500 mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by healthcare providers, self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on your condition's severity, adhering strictly to prescribed guidelines. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rash, and localized injection site reactions (pain, swelling, redness). Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, liver, or kidney issues; adjustments to dosage or alternative medications may be necessary. Generally safe during pregnancy and lactation under professional medical guidance.
Uses of Improtaz 4000 mg/500 mg Injection
Infections caused by bacteria
Major Benefits of Improtaz 4000 mg/500 mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Improtaz 4000 mg/500 mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Improtaz 4000 mg/500 mg Injection:
Administering this medication will be done by your physician or registered nurse; self-medication is strictly prohibited.
How Improtaz 4000 mg/500 mg Injection works:
Improtaz Injection, containing 4000 mg piperacillin and 500 mg tazobactam, employs a dual-drug approach to combat bacterial infections. Piperacillin, an antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Tazobactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby bolstering piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Improtaz 4000 mg/500 mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Improtaz (4000 mg/500 mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to offspring; nevertheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Improtaz, 4000 mg/500 mg, is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no appreciable risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Improtaz 4000 mg/500 mg Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
The administration of Improtaz 4000 mg/500 mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification of Improtaz 4000 mg/500 mg Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Improtaz 4000 mg/500 mg Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Improtaz 4000 mg/500 mg Injection :
Omitting a scheduled dose of Improtaz 4000 mg/500 mg Injection warrants immediate physician consultation.
Facts to Know About Improtaz 4000 mg/500 mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently